📂 Drugs
belantamab mafodotin — Definition
belantamab mafodotin / belantamab mafodotin
Belantamab mafodotin is a target antibody-drug conjugat with B cell ripening antigen (BCMA). In the treatment of multipl myeloma, it is mainly used in adult patients with at least four treatment regimes and refractory disease. The drug is taken into the cell by connecting to BCMA and cytotoxic agent kills tumor cells through the release of monomethyl auristatin F (MMAF). In clinical practice, it is usually applied in three weeks through intravenous infusion and contains keratopathy, thrombocytopenia and infusion reactions among common side effects.
Frequently Asked Questions
❓ What is belantamab mafodotin?
belantamab mafodotin; belantamab mafodotin is a target antibody-drug conjugat with B cell ripening antigen (BCMA). In the treatment of multipl myeloma, it is mainly used in adult patients with at least four treatment regimes and refractory disease. The drug is taken into the cell by connecting to BCMA and cytotoxic agent kills tumor cells through the release of monomethyl auristatin F (MMAF). In clinical practice, it is usually applied in three weeks through intravenous infusion and contains keratopathy, thrombocytopenia and infusion reactions among common side effects.
❓ What is belantamab mafodotin in Turkish?
The Turkish equivalent of "belantamab mafodotin" is belantamab mafodotin.
❓ Which medical field is belantamab mafodotin related to?
This term belongs to the Drugs category.